---
figid: PMC5618570__ijms-18-01921-g001
figtitle: Insulin/insulin-like growth factor (IGF) system
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC5618570
filename: ijms-18-01921-g001.jpg
figlink: /pmc/articles/PMC5618570/figure/ijms-18-01921-f001/
number: F1
caption: 'The insulin/insulin-like growth factor (IGF) system. The ligands (insulin,
  IGF1 and IGF2) bind to their specific receptors triggering downstream signaling
  pathways (RAS/MEK/ERK and PI3K/AKT1/mTORC1) through IRS proteins, with the exception
  of IGFR2 that does not transduce signaling. The IGFBPs negatively modulate both
  IGF1 and IGF2. The activation of RAS/MEK/ERK pathway has been shown to be involved
  in the upregulation of MGAT5 gene, increasing the levels of expression of β1,6-branched
  N-glycans. On the contrary, the activation of PI3K/AKT/mTOR signaling cascade was
  associated with the impairment of GnT-III-mediated bisecting GlcNAc N-glycans expression.
  These signaling pathways have an impact on cell growth, survival and invasion, which
  favors tumour development and progression. GnT-III: N-acetylglucosaminyltransferase
  III; GnT-V: N-acetylglucosaminyltransferase V. GnT-III catalyzes the bisecting GlcNAc
  N-glycan structure and GnT-V catalyzes the β1,6 GlcNAc branched N-glycans.'
papertitle: 'Glycans as Regulatory Elements of the Insulin/IGF System: Impact in Cancer
  Progression.'
reftext: Julio Cesar M. de-Freitas-Junior, et al. Int J Mol Sci. 2017 Sep;18(9):1921.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9453615
figid_alias: PMC5618570__F1
figtype: Figure
redirect_from: /figures/PMC5618570__F1
ndex: 8abdf657-deea-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5618570__ijms-18-01921-g001.html
  '@type': Dataset
  description: 'The insulin/insulin-like growth factor (IGF) system. The ligands (insulin,
    IGF1 and IGF2) bind to their specific receptors triggering downstream signaling
    pathways (RAS/MEK/ERK and PI3K/AKT1/mTORC1) through IRS proteins, with the exception
    of IGFR2 that does not transduce signaling. The IGFBPs negatively modulate both
    IGF1 and IGF2. The activation of RAS/MEK/ERK pathway has been shown to be involved
    in the upregulation of MGAT5 gene, increasing the levels of expression of β1,6-branched
    N-glycans. On the contrary, the activation of PI3K/AKT/mTOR signaling cascade
    was associated with the impairment of GnT-III-mediated bisecting GlcNAc N-glycans
    expression. These signaling pathways have an impact on cell growth, survival and
    invasion, which favors tumour development and progression. GnT-III: N-acetylglucosaminyltransferase
    III; GnT-V: N-acetylglucosaminyltransferase V. GnT-III catalyzes the bisecting
    GlcNAc N-glycan structure and GnT-V catalyzes the β1,6 GlcNAc branched N-glycans.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - IGF2
  - AGFG1
  - IGF2R
  - IGF1R
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - RPTOR
  - MGAT2
  - igf1
  - igf2a
  - agfg1a
  - igf2r
  - insrb
  - insra
  - rab1ab
  - akt1
  - Cancer
---
